Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diffuse Intrinsic Pontine Glioma × Drug Therapy × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 17 Brain Neoplasms 14 Central Nervous System Neoplasms 10 Gliosarcoma 7 Glioma 7 Neuroblastoma 6 Neoplasms 5 Astrocytoma 5 Recurrence 3 Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Meningeal Carcinomatosis 2 Melanoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Ovarian Neoplasms 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Head and Neck Neoplasms 1 Glioma, Subependymal 1

Interventions

Temozolomide 15 Radiotherapy 10 Bevacizumab 6 Irinotecan 5 Everolimus 5 Cyclophosphamide 5 ribociclib 4 Radiation 4 TIC10 compound 3 Re-Irradiation 3 Panobinostat 3 Etoposide 3 Dasatinib 3 pembrolizumab 2 nimotuzumab 2 abemaciclib 2 Vorinostat 2 Valproic Acid 2 Topotecan 2 Specimen Handling 2 Nivolumab 2 Mebendazole 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 GDC-0084 2 Erlotinib Hydrochloride 2 Diphtheria-Tetanus Vaccine 2 Cilengitide 2 Cetuximab 2 1-methyltryptophan 2 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03620032 2023-12-06

DIPG

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡